135 completed, 11 terminated, 5 active not recruiting, 2 unknown. 69 Not applicable, 29 Phase 4, 17 Phase 3, 11 Phase 2, 10 Phase 1.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Powered vs Manual Toothbrush Use: Its Effect on Caries Risk in Pre-Adolescents Powered toothbrush - Caries Risk, Caries, Dental | Not applicable | Recruiting | University of Michigan | 30 | 2026-10-28 | 2026-10-08 |
| Assessing Gingivitis and Plaque From a Marketed Toothpaste Stannous Fluoride Dentifrice, Test Stannous Fluoride Dentifrice, Sodium monofluorophosphate dentifrice - Gingivitis | Phase 4 | Active not recruiting | Procter and Gamble | 120 | 2025-08-30 | 2025-09-23 |
| Earlier Diagnosis of Peripheral Neuropathy Using A Simple sCreening Tool (ACT) Peripheral Neuropathy, Painful Neuropathy | Active not recruiting | Weill Cornell Medical College in Qatar | 150 | 2025-05-11 | 2025-09-09 | |
| Evaluating Gingivitis and Systemic Biomarkers 0.76% Sodium Monofluorophosphate Dentifrice, 0.454% Stannous Fluoride Dentifrice - Gingivitis | Phase 1 | Active not recruiting | Procter and Gamble | 135 | 2025-04-30 | 2025-06-03 |
| Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control. Stannous Fluoride Dentifrice, Sodium Fluoride Dentifrice, Sodium monofluorophosphate dentifrice - Gingivitis | Phase 2 | Completed | Procter and Gamble | 120 | 2025-03-25 | 2026-05-04 |
| Bodewell Products for the Treatment of Atopic Dermatitis Bodewell Calming Cream - Atopic Dermatitis | Phase 4 | Active not recruiting | University of Alabama at Birmingham | 15 | 2023-11-01 | 2026-03-02 |
| A Clinical Study to Assess the Gingivitis and Plaque Effects of Various Dentifrices 0.76% Sodium Monofluorophosphate Dentifrice, 0.454% Stannous Fluoride Dentifrice - Gingivitis | Not applicable | Completed | Procter and Gamble | 116 | 2023-09-02 | 2024-03-01 |
| Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model Oral-B 1450 ppm Fluoride (1.16% sodium monofluorophosphate) Dentifrice, Colgate 1450 ppm Fluoride (1.16% sodium monofluorophosphate)Dentifrice, Toms of Maine 0 ppm Fluoride Dentifrice - Caries | Not applicable | Completed | Procter and Gamble | 12 | 2023-07-31 | 2024-02-29 |
| A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies. Vitamin B combination tablet, Placebo Tablet - Peripheral Sensory Neuropathy of Different Etiologies | Phase 3 | Completed | Procter and Gamble | 323 | 2022-09-06 | 2023-11-28 |
| Stannous Fluoride and Gingivitis Stannous fluoride - Gingivitis | Not applicable | Completed | Procter and Gamble | 40 | 2022-04-11 | 2022-06-16 |
| A Meta-analysis Comparing Toothbrushes on Plaque Removal and Gingival Health Oscillating-rotating electric toothbrush, Sonic electric toothbrush, Manual toothbrush - Gingivitis, Dental Plaque | Completed | Procter and Gamble | 2929 | 2022-04-01 | 2022-10-26 | |
| Brief Title: a Clinical Study to Assess Gingivitis 0.76% Sodium Monofluorophosphate Dentifrice, 0.454% Stannous Fluoride Dentifrice - Gingival Diseases | Not applicable | Completed | Procter and Gamble | 120 | 2022-03-07 | 2024-10-26 |
| Overnight Pant Study for Children With Nocturnal Enuresis Ninjamas Pyjama Pants, Participant's Overnight Current Standard of Care - Nocturnal Enuresis | Not applicable | Completed | Procter and Gamble | 32 | 2022-01-13 | 2024-10-01 |
| A Three Month Bleeding-Model Clinical Study 0.454% stannous fluoride, 0.76% sodium monofluorophosphate, 0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM - Gingivitis | Not applicable | Completed | Procter and Gamble | 90 | 2021-11-15 | 2023-06-23 |
| A Clinical Study to Assess the Gingivitis Effects of Various Dentifrices 0.76% Sodium Monofluorophosphate Dentifrice, 1.15% Sodium Monofluorophosphate Dentifrice, 0.454% Stannous Fluoride Dentifrice - Gingivitis | Not applicable | Completed | Procter and Gamble | 115 | 2021-10-20 | 2023-11-20 |
| Salivary Fluoride Clearance 0 ppm F, 250 ppm F as MFP, 1100 ppm as MFP - Caries | Phase 1 | Completed | Procter and Gamble | 27 | 2021-07-14 | 2024-12-16 |
| Measuring Efficacy of an Oral-Irrigator After Three Weeks of Use Water Flosser, Control - Gingivitis, Plaque | Completed | Procter and Gamble | 30 | 2021-06-03 | 2022-08-01 | |
| Assessing Effects of a Denture Gel on Gum Abrasions Treatment Gel, Sham Control - Gum Injury | Not applicable | Completed | Procter and Gamble | 38 | 2021-06-01 | 2022-06-28 |
| Evaluation of the Fluoride Dose Response Using In Situ Caries Model 0 ppm F, 250 ppm F as MFP, 1100 ppm as MFP - Caries | Phase 4 | Completed | Procter and Gamble | 15 | 2021-03-01 | 2022-07-19 |
| Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol) Bismuth Subsalicylate 262 milligram (mg) Oral Tablet, Chewable, Placebo oral tablet without BSS - Diarrhea, COVID-19 | Phase 4 | Completed | University of Cincinnati | 60 | 2020-10-27 | 2023-03-01 |
Showing 20 of 154. Sign in to see all of them.
Gingivitis (22) · Osteoporosis (12) · Dentin Sensitivity (11) · Hypersensitivity (8) · Osteoporosis, Postmenopausal (8) · Colitis, Ulcerative (6) · Dental Plaque (5) · Urinary Bladder, Overactive (5) · Plaque, Amyloid (4) · Vitamin D Deficiency (4) · Bone Diseases, Metabolic (3) · Diarrhea (3) · Urinary Incontinence, Stress (3) · Colitis (2) · Common Cold (2)
Risedronic Acid (16) · Tin Fluorides (7) · darifenacin (6) · Calcium (4) · Mesalamine (4) · Psyllium (4) · Vitamin D (4) · fluorophosphate (3) · ATI 7505 (2) · Alendronate (2) · Cetylpyridinium (2) · Dental Devices, Home Care (2) · Dioctyl Sulfosuccinic Acid (2) · Hand Disinfection (2) · Nutrition Assessment (2)
United States (110) · Canada (11) · United Kingdom (10) · Netherlands (6) · Australia (5) · France (5) · Poland (4) · Czechia (3) · Germany (3) · Pakistan (3) · Belgium (2) · China (2) · Guatemala (2) · Hungary (2) · Spain (2)
Jose Brum, MD (4) · Robert W Gerlach, DDS, MPH (4) · Randall Severance, MD (3) · Anna Bowen, MD, MPH (2) · Laura A Armas, MD (2) · Walter J Doll, PhD, RPh (2) · William S Aronstein, MD, PhD (2) · Aaron Biesbrock, DMD, PhD (1) · Amanda Salisbury, BSN (1) · Amy J McMichael, MD (1) · Amy McMichael, MD (1) · Angela Rogers, Dr (1)
PMID 39118360, PMID 16553931, PMID 17200474, PMID 17244788, PMID 17641811, PMID 17958901, PMID 17998493, PMID 18035193, PMID 18326608, PMID 18427147, PMID 18682511, PMID 18779444, PMID 18811599, PMID 19333675, PMID 19389560, PMID 1955657, PMID 19853693, PMID 20063223, PMID 20089518, PMID 20129531, PMID 20435202, PMID 20501476, PMID 20850849, PMID 20860020, PMID 20863398, PMID 20880552, PMID 21059712, PMID 21304097, PMID 21311871, PMID 21927921, PMID 22589297, PMID 22795281, PMID 22814783, PMID 22836812, PMID 22986783, PMID 23351826, PMID 23453104, PMID 23504379, PMID 23549644, PMID 24176448, PMID 24519745, PMID 24780062, PMID 26523214, PMID 27845337, PMID 28274254, PMID 29445831, PMID 31418805, PMID 31562774, PMID 36625789, PMID 37127210
M01RR000030 (1)